Malaria Clinical Trial
Official title:
Evaluating the Impact of Enhanced Health Facility-based Care for Malaria and Febrile Illnesses in Children in Tororo, Uganda
The investigators propose to assess whether an intervention to build capacity and improve delivery of drugs and diagnostics at government-run health facilities improves the health of children and quality of care delivered, as compared to 'standard care' currently available at health facilities, supplemented by services provided through the private sector and community-based interventions. The target population will be divided into 20 clusters, defined as the catchment area of lower-level public health facilities. Clusters will be randomized to the health facility intervention (HFI) or to standard care delivered from government-run health facilities, supplemented by services provided through the private sector and community-based interventions. The intervention is designed to address barriers to delivering quality care at health centers and will focus on three components: (1) training in-charges in health center management, (2) providing training to health workers in fever case management and patient-centered services, and (3) ensuring adequate supplies of artemether-lumefantrine and RDTs. Outcomes will be measured in three distinct populations: (1) cross-sectional surveys of children under 15 years randomly selected from households within the clusters; (2) a cohort of children under five randomly selected from households within the clusters and followed for 2 years; and (3) patients attending all government-run health facilities, including children under five and their caregivers participating in exit interviews on selected days every six months. The primary outcome of the study is prevalence of anemia in children under five.
Study overview:
We are proposing to evaluate enhanced health facility-based care for malaria and febrile
illnesses in children in Tororo district using a cluster randomized design. The health
facility intervention (HFI) will aim to address barriers to achieving good quality health
care that were identified in our formative research. The focus of our intervention will be
providing RDTs and training health workers in management of both malaria and non-malarial
febrile illnesses.
Study site:
The study will be conducted in Tororo district, an area with very high malaria transmission
intensity. The estimated entomologic inoculation rate (EIR) in Tororo is 562 infective bites
per person-year, and the prevalence of parasitemia among children aged 5-9 years is 63.5%.
The five sub-counties of West Budama North Health Sub-district (Nagongera, Paya, Kirewa,
Kisoko, and Petta), and two sub-counties of West Budama South Health Sub-district (Mulanda
and Rubongi) will be included in the study population.
Study population:
Within the seven sub-counties, there are 22 lower-level government run health facilities,
including 17 level II health centers (HC), and 5 level III HCs; 20 will be included in the
randomization scheme.
Randomization:
The lower-level government-run health facilities in the study area will be the unit of
randomization. Clusters will be defined as the catchment areas of the health centers,
including households located within a 2km radius of the facilities. The clusters will be
defined prior to randomization using the full census survey database. Households will be
excluded from our sampling frame if they are > 2km from any health facility. The
randomization will be conducted by an investigator who is not directly involved in the
project. Health facilities will be stratified by level (HC IIs and HC IIIs). Because of the
uneven numbers of HC IIs and IIIs, one of the HC IIIs without a laboratory will be 'demoted'
and paired with a HC II to ensure even numbers. Restricted randomization will be employed to
ensure balance on geographical location. Specifically, restrictions will be applied that
exclude the allocation of all clusters originating from a single sub-county, or that are
otherwise in close geographical proximity from being allocated to the same arm of the trial.
The Health Facility Intervention:
The intervention is designed to address barriers to delivering quality care at health
centers and will focus on three components: (1) training in-charges in health center
management, (2) providing training to health workers in fever case management and
patient-centered services, and (3) ensuring adequate supplies of artemether-lumefantrine and
RDTs.
1. Training in-charges:
All in-charges of health centers randomized to the HFI will be trained in health center
management. The purpose of this training is to equip in-charges with the skills and
tools required to effectively and efficiently manage their health center. The training
will include three components: (1) financial management, (2) supply management, and (3)
information management.
2. Health worker training:
A)Training in fever case management and use of RDTs All clinical staff will receive
training in fever case management. Training will be based on the Integrated Malaria
Management training package developed by the Joint Uganda Malaria Training Program
(JUMP) team, and the RDT training guidelines which have been adopted and implemented by
Uganda's MoH 'User's manual: Use of Rapid Diagnostic Tests (RDTs) for malaria in fever
case management in Uganda'. The training program will be conducted by the JUMP training
team over two weeks; the first two days will focus on theory, and will be followed by
support supervision at the health facilities the next week. The training will be
conducted in Tororo at a local health facility, and health workers will be trained in
two small groups to ensure that work at the health facilities continues alongside the
training. The impact of training on knowledge will be assessed using a pre-and
post-training evaluation administered by the JUMP team. Additional support supervision
will be conducted at 6 weeks and 6 months after the initial training and refresher
training will be provided as needed.
B)Training in patient-centered services The purpose of the Patient-Centered Services
(PCS) training module is to identify and improve interpersonal interactions between
health workers and patients. The module builds on the results of our formative research
which identified several barriers to proving good quality health care at health
facilities, including poor interpersonal interactions between health workers and
community members resulting from poor communication skills, discriminatory behaviors of
health workers, poor health worker motivation, and lack of patient-centered thinking.
Through the PCS module, health workers will learn to recognize these challenges and
develop skills for communicating and interacting with patients. The PCS module training
will be implemented in a tiered approach to (1) all clinical staff, and (2) all health
center support staff. All clinical staff, including in-charges, will receive the full
PCS training package which includes self-observation tasks and specific emphasis on
clinical and patient interaction challenges. Support staff including volunteers will
receive a scaled-down PCS training package with specific emphasis on welcoming and
guiding patients at the health facility. All training activities and workshops will be
led by study personnel and trainers with experience in adult learning methodology.
3. Supply of AL and RDTs for malaria If the amount of AL provided to the intervention
health centers by NMS is not adequate to meet demand, or if the procurement of AL
fails, the project will supply supplemental AL. In addition, we will ensure adequate
supplies of RDTs at all intervention health centers.
Evaluation procedures:
Outcomes will be measured in three distinct populations: (1) cross-sectional surveys of
children under 15 years randomly selected from households within the clusters; (2) a cohort
of children under five randomly selected from households within the clusters and followed
for 2 years; and (3) patients attending all government-run health facilities, including
children under five and their caregivers participating in exit interviews on selected days
every six months.
1. Cross-sectional surveys will be conducted in randomly selected children under-five, and
those between the ages of 5-15 years of age. The number of children sampled will be
weighted according to the total population of each cluster to achieve a harmonic mean
of 200 for each age category. A total of 8766 children will be sampled in each survey.
Surveys will be conducted at baseline and then annually for each year; new populations
of children will be selected for each survey. The survey will include a structured
questionnaire administered to the primary caregiver, and a clinical and laboratory
assessment of each child.
2. A Cohort of children under five will be enrolled from 25 households randomly selected
from each cluster, for a total of 500 households. The cohort will be dynamic, in that
all children within a household, who are under the age of five and who meet selection
criteria, will be included. A household survey will be conducted at the start of the
study. Children will undergo clinical and laboratory assessments at baseline and then
every six months. Primary caregivers will be asked to prospectively collect information
on the clinical symptoms of participating children and expenditures for health care
using pictorial diaries. Study personnel will visit the households monthly to collect
the diaries and administer a monthly questionnaire. Participants will be followed for
approximately 18 months in total, the equivalent of approximately 12 months following
roll-out of the intervention.
3. Patient Exit Interviews will be conducted with children under five and their caregivers
at all health facilities. The purpose of the interviews is to evaluate for rational
prescribing of ACTs, and to determine the level of satisfaction with the health
facility visit. Three rounds of surveys are planned. In the first two surveys, 10
patients will be selected by convenience sampling from each facility to participate in
the interviews (200 total per survey). In the final survey, 50 patients will be
recruited to participate (1000 total in survey). In total, 1400 patients will
participate in the interviews.
;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Health Services Research
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04601714 -
Baseline Cohort Malaria Morbidity Study
|
||
| Withdrawn |
NCT04020653 -
A Study to Assess the Safety and Efficacy of 5-aminolevulinic Acid Hydrochloride (5-ALA HCl) and Sodium Ferrous Citrate (SFC) Added on Artemisinin-based Combination Therapy (ACT) in Adult Patients With Uncomplicated Malaria
|
Phase 2 | |
| Terminated |
NCT04368910 -
Safety and Efficacy of Pyronaridine Artesunate Vs Chloroquine in Children and Adult Patients With Acute Vivax Malaria
|
Phase 3 | |
| Completed |
NCT03641339 -
Defining Skin Immunity of a Bite of Key Insect Vectors in Humans
|
N/A | |
| Completed |
NCT02544048 -
Markers of T Cell Suppression: Antimalarial Treatment and Vaccine Responses in Healthy Malian Adults
|
||
| Completed |
NCT00527163 -
Role of Nitric Oxide in Malaria
|
||
| Not yet recruiting |
NCT05934318 -
L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE)
|
N/A | |
| Active, not recruiting |
NCT04704674 -
Community Dynamics of Malaria Transmission in Humans and Mosquitoes in Fleh-la and Marshansue, Salala District, Bong County, Liberia
|
||
| Completed |
NCT03276962 -
Efficacy, Safety and Immunogenicity Study of GSK Biologicals' Candidate Malaria Vaccine (SB257049) Evaluating Schedules With or Without Fractional Doses, Early Dose 4 and Yearly Doses, in Children 5-17 Months of Age
|
Phase 2 | |
| Completed |
NCT04966871 -
Safety, Tolerability and Efficacy of PfSPZ Vaccine Against Heterologous CHMI in US Malaria naïve Adults
|
Phase 1 | |
| Completed |
NCT00289185 -
Study of Safety, Immunogenicity and Efficacy of a Candidate Malaria Vaccine in Tanzanian Infants
|
Phase 2 | |
| Recruiting |
NCT03937817 -
Collection of Human Biospecimens for Basic and Clinical Research Into Globin Variants
|
||
| Active, not recruiting |
NCT06153862 -
Africa Ready Malaria Screening
|
N/A | |
| Completed |
NCT04545905 -
Antenatal Care as a Platform for Malaria Surveillance: Utilizing Community Prevalence Measures From the New Nets Project to Validate ANC Surveillance of Malaria in Burkina Faso
|
||
| Recruiting |
NCT06278181 -
Diabetes, Metabolic Syndrome and Risk of Malaria in Cameroon
|
||
| Completed |
NCT02909712 -
Cardiac Safety of Dihydroartemisinin-Piperaquine Amongst Pregnant Women in Tanzania
|
Phase 2 | |
| Withdrawn |
NCT02793414 -
Diagnostic Utility of Volatile Organic Compounds in Human Breath for Acute Clinical Malaria in Ethiopia
|
||
| Completed |
NCT02793622 -
Prevention of Malaria in HIV-uninfected Pregnant Women and Infants
|
Phase 3 | |
| Withdrawn |
NCT02793388 -
A Trial on Supervised Primaquine Use in Ethiopia
|
Phase 4 | |
| Completed |
NCT02605720 -
Cardiac Safety of Repeated Doses of Dihydroartemisinin-Piperaquine for the Use in Mass Treatment Campaigns
|
Phase 3 |